Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of sirolimus for complex renal angiomyolipoma
ChiCTR-ONRC-12002287Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sirolimus in kidney angiomyolipoma (AML) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Objective response as assessed by RECIST criteria and Adverse event. Started Aug 2012; status: recruiting.
02
Drugs
sirolimus
03
Conditions
kidney angiomyolipoma (AML)
Beyond the preview
Go deeper on ChiCTR-ONRC-12002287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002287.